Abstract:RNA interference mediated by small interfering RNAs (siRNA) has emerged as a powerful tool to target specific knockdown of gene expression in cell culture. siRNA is now the gold standard technique to study gene function, and expectations for the development of new target-specific drugs are high. In addition to the gene-silencing activity of siRNA, a number of recent studies have pointed to immunological effects of siRNAs, including the induction of proinflammatory cytokines and type I interferon. There is good evidence that gene silencing and immunostimulation are two independent functional characteristics of RNA oligonucleotides. Immunorecognition of RNA depends on certain molecular features such as length, double- versus single-strand configuration, sequence motifs, and nucleoside modifications such as triphosphate residues. RNA-sensing immunoreceptors include three members of the Toll-like receptor (TLR) family (TLR3, TLR7, TLR8) and cytosolic RNA-binding proteins like PKR and the helicases RIG-I and Mda5. Detection of RNA molecules occurs during viral infection and triggers antiviral innate defense mechanisms including the induction of type I interferons (IFN-α, IFN-β) and downregulation of gene expression. Type I interferon induction by synthetic siRNAs requires TLR7 and is sequence dependent, similar to the detection of CpG motifs in DNA by TLR9. Identification of the exact molecular mechanisms of immunorecognition of RNA will allow the development of methods to avoid immunostimulation of siRNA and the design of potent immunostimulatory RNA (isRNA) oligonucleotides, depending on the aim. Furthermore, the combination of both gene-silencing and immunostimulation in one RNA molecule may lead to novel drugs that use both functional activities of RNA as two edges of one sword for effective treatment of viral infection and cancer.

Engineering of the mRNA-interfering complementary RNA immune system against viral infection

Artificial immune system against viral infection involving antisense RNA targeted to the 5'-terminal noncoding region of coliphage SP RNA

Efficient Inhibition of Human Cytomegalovirus UL122 Gene Expression in Cell by Small Interfering RNAs

Efficient Inhibition of Human Cytomegalovirus DNA Polymerase Expression by Small Hairpin RNA in Vitro

Engineered External Guide Sequences Effectively Block Viral Gene Expression and Replication in Cultured Cells

Ribonuclease P-mediated inhibition of human cytomegalovirus gene expression and replication induced by engineered external guide sequences.

TALEN/CRISPR-mediated Engineering of a Promoterless Anti-Viral RNAi Hairpin into an Endogenous Mirna Locus

RNA Interference: Its Use as Antiviral Therapy

Inhibition Of Sars-Cov Gene Expression By Adenovirus-Delivered Small Hairpin Rna

A Lentiviral Microrna-Based System for Single-Copy Polymerase II-regulated RNA Interference in Mammalian Cells

Efficient Inhibition of HIV-1 Replication by an Artificial Polycistronic Mirna Construct

Effective Inhibition in Animals of Viral Pathogenesis by a Ribozyme Derived from RNase P Catalytic RNA.

SY-9 Stimulation of Innate Immunity by Short Interfering and Micro RNAs

Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals.

Complete substitution with modified nucleotides suppresses the early interferon response and increases the potency of self-amplifying RNA

RNA Interference of Influenza Virus Production by Directly Targeting Mrna for Degradation and Indirectly Inhibiting All Viral RNA Transcription

Engineering of RNase P Ribozymes for Therapy against Human Cytomegalovirus Infection

Anti-viral defence by an mRNA ADP-ribosyltransferase that blocks translation

Design of a self-regulating mRNA gene circuit

Effective Inhibition of Human Cytomegalovirus Gene Expression and Growth by Intracellular Expression of External Guide Sequence RNA